Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Zimmer Biomet (ZBH) PT Raised to $132 at Oppenheimer Following 4Q Report
February 1, 2017 10:51 AM ESTOppenheimer raised its price target on Zimmer Biomet (NYSE: ZBH) to $132.00 (from $126.00) while maintaining a Outperform rating.
Analyst Steven Lichtman commented, "4Q16 sales of $2.013B (+3.0% organic, ex-stocking/FX, day-adjusted) were in line with ZBH's above consensus pre-announcement earlier in January; recall Americas... More
Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 3c; Guides In-Line
January 31, 2017 7:34 AM ESTZimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.14, $0.03 better than the analyst estimate of $2.11. Revenue for the quarter came in at $2.01 billion versus the consensus estimate of $1.98 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2017 EPS of $8.50-$8.68, versus the consensus of... More
